Literature DB >> 15580348

Suppressive effects of hyaluronan on MMP-1 and RANTES production from chondrocytes.

Michiaki Tanaka1, Kayo Masuko-Hongo, Tomohiro Kato, Kusuki Nishioka, Hiroshi Nakamura.   

Abstract

The purpose of the study was to examine the effects of hyaluronan (HA) on human chondrocytes in terms of production of MMP-1 and RANTES. Chondrocytes were obtained from patients with osteoarthritis (OA) or femoral neck fracture (control). Chondrocytes in monolayer culture were treated with various molecular weights (1.2, 50, 800 and 1,900 kD) of HA and then stimulated with IL-1beta. Production and expression of MMP-1 and RANTES were quantified by ELISA and real-time polymerase chain reaction (PCR). The response was blocked by anti-CD44 antibody. Production of MMP-1 was significantly suppressed by both 800- and 1,900-kD HA, while production of RANTES was suppressed by 1,900-kD HA. Expression of MMP-1 and RANTES mRNA was inhibited by 1,900-kD HA. Suppressive effects of HA on production of MMP-1 were canceled by treatment of anti-CD44 antibody. Higher CD44 expression was found in OA chondrocytes than in those of control. High-molecular-weight HA suppressed MMP-1 and RANTES production, mediated partly by CD44-HA interaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15580348     DOI: 10.1007/s00296-004-0547-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

Review 1.  Signaling properties of hyaluronan receptors.

Authors:  Eva A Turley; Paul W Noble; Lilly Y W Bourguignon
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

Review 2.  Hyaluronan--magic glue for the regulation of the immune response?

Authors:  Christian Termeer; Jonathan P Sleeman; Jan C Simon
Journal:  Trends Immunol       Date:  2003-03       Impact factor: 16.687

3.  Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.

Authors:  M D Smith; S Triantafillou; A Parker; P P Youssef; M Coleman
Journal:  J Rheumatol       Date:  1997-02       Impact factor: 4.666

4.  Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain.

Authors:  D Liu; M S Sy
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

5.  Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1.

Authors:  K Fukuda; H Dan; M Takayama; F Kumano; M Saitoh; S Tanaka
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

6.  Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis.

Authors:  Grace H Lo; Michael LaValley; Timothy McAlindon; David T Felson
Journal:  JAMA       Date:  2003-12-17       Impact factor: 56.272

7.  Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines.

Authors:  Makoto Shimizu; Tadashi Yasuda; Takefumi Nakagawa; Eizaburo Yamashita; Sohel M Julovi; Teruko Hiramitsu; Takashi Nakamura
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

8.  Osteoarthritic lesions: involvement of three different collagenases.

Authors:  B V Shlopov; W R Lie; C L Mainardi; A A Cole; S Chubinskaya; K A Hasty
Journal:  Arthritis Rheum       Date:  1997-11

9.  The effect of hyaluronan on interleukin-1 alpha-induced prostaglandin E2 production in human osteoarthritic synovial cells.

Authors:  T Yasui; M Akatsuka; K Tobetto; M Hayaishi; T Ando
Journal:  Agents Actions       Date:  1992-09

10.  Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage.

Authors:  Sohel M Julovi; Tadashi Yasuda; Makoto Shimizu; Teruko Hiramitsu; Takashi Nakamura
Journal:  Arthritis Rheum       Date:  2004-02
View more
  9 in total

1.  Intra-articular hyaluronate, tenoxicam and vitamin E in a rat model of osteoarthritis: evaluation and comparison of chondroprotective efficacy.

Authors:  Feyza Unlu Ozkan; Gokcer Uzer; Ismail Türkmen; Yavuz Yildiz; Serkan Senol; Korhan Ozkan; Fatih Turkmensoy; Saime Ramadan; Ilknur Aktas
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Hyaluronic acid (Supartz®): a review of its use in osteoarthritis of the knee.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2010-11-01       Impact factor: 3.923

3.  Anti-inflammatory effects of hyaluronan in arthritis therapy: Not just for viscosity.

Authors:  Kayo Masuko; Minako Murata; Kazuo Yudoh; Tomohiro Kato; Hiroshi Nakamura
Journal:  Int J Gen Med       Date:  2009-07-30

4.  Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism.

Authors:  Jun Li; Daniel J Gorski; Wendy Anemaet; Jennifer Velasco; Jun Takeuchi; John D Sandy; Anna Plaas
Journal:  Arthritis Res Ther       Date:  2012-06-21       Impact factor: 5.156

5.  A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan.

Authors:  Margaret M Smith; Amy K Russell; Antonella Schiavinato; Christopher B Little
Journal:  J Inflamm (Lond)       Date:  2013-07-27       Impact factor: 4.981

6.  Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.

Authors:  María Permuy; David Guede; Mónica López-Peña; Fernando Muñoz; José-Ramón Caeiro; Antonio González-Cantalapiedra
Journal:  BMC Musculoskelet Disord       Date:  2015-05-20       Impact factor: 2.362

Review 7.  The Disease-Modifying Effects of Hyaluronan in the Osteoarthritic Disease State.

Authors:  Mathew A Nicholls; Anke Fierlinger; Faizan Niazi; Mohit Bhandari
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2017-08-11

Review 8.  The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review.

Authors:  R D Altman; A Manjoo; A Fierlinger; F Niazi; M Nicholls
Journal:  BMC Musculoskelet Disord       Date:  2015-10-26       Impact factor: 2.362

9.  The efficacy and safety of intra-articular injection of hyaluronic acid in the knee and physical therapy agents to treat Kashin-Beck disease: A prospective interventional study.

Authors:  Pinglin Yang; Xiong Guo; Xijing He; Quanjin Zang; Guoyu Wang; Peng Xu; Weizhuo Wang
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.